5,418 Shares in Humana Inc. (NYSE:HUM) Bought by Fiduciary Alliance LLC

Fiduciary Alliance LLC acquired a new position in shares of Humana Inc. (NYSE:HUM) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 5,418 shares of the insurance provider’s stock, valued at approximately $1,375,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Marshall Wace LLP boosted its stake in shares of Humana by 118.9% during the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after purchasing an additional 774,085 shares during the period. International Assets Investment Management LLC grew its stake in shares of Humana by 261,025.1% during the third quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after buying an additional 738,701 shares during the last quarter. FMR LLC raised its holdings in shares of Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after buying an additional 643,291 shares during the period. Baupost Group LLC MA bought a new stake in shares of Humana during the 2nd quarter worth approximately $156,933,000. Finally, Thrivent Financial for Lutherans boosted its holdings in Humana by 639.8% during the 2nd quarter. Thrivent Financial for Lutherans now owns 385,782 shares of the insurance provider’s stock valued at $144,147,000 after acquiring an additional 333,636 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on HUM. Deutsche Bank Aktiengesellschaft decreased their target price on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Piper Sandler lowered shares of Humana from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $392.00 to $274.00 in a report on Thursday, October 3rd. Truist Financial upped their target price on shares of Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Morgan Stanley lifted their price target on shares of Humana from $288.00 to $301.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Finally, Leerink Partners cut Humana from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Twenty research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, Humana presently has an average rating of “Hold” and a consensus target price of $302.00.

Insider Activity

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.32% of the company’s stock.

Humana Stock Up 6.9 %

Humana stock opened at $287.48 on Tuesday. The business has a fifty day moving average price of $273.89 and a 200-day moving average price of $309.74. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $455.53. The stock has a market capitalization of $34.62 billion, a price-to-earnings ratio of 25.46, a PEG ratio of 2.12 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Equities research analysts forecast that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.23%. Humana’s payout ratio is currently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.